NTLA
Price
$16.34
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
2 days until earnings call
PLX
Price
$1.13
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
8 days until earnings call
Ad is loading...

NTLA vs PLX

Header iconNTLA vs PLX Comparison
Open Charts NTLA vs PLXBanner chart's image
Intellia Therapeutics
Price$16.34
Change-$0.00 (-0.00%)
Volume$3.31M
CapitalizationN/A
Protalix BioTherapeutics
Price$1.13
Change-$0.00 (-0.00%)
Volume$237.29K
CapitalizationN/A
View a ticker or compare two or three
NTLA vs PLX Comparison Chart
Loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
NTLA vs. PLX commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTLA is a Buy and PLX is a StrongBuy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (NTLA: $16.34 vs. PLX: $1.13)
Brand notoriety: NTLA and PLX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTLA: 172% vs. PLX: 163%
Market capitalization -- NTLA: $2.13B vs. PLX: $75.01M
NTLA [@Biotechnology] is valued at $2.13B. PLX’s [@Biotechnology] market capitalization is $75.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTLA’s FA Score shows that 0 FA rating(s) are green whilePLX’s FA Score has 0 green FA rating(s).

  • NTLA’s FA Score: 0 green, 5 red.
  • PLX’s FA Score: 0 green, 5 red.
According to our system of comparison, NTLA is a better buy in the long-term than PLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTLA’s TA Score shows that 4 TA indicator(s) are bullish while PLX’s TA Score has 5 bullish TA indicator(s).

  • NTLA’s TA Score: 4 bullish, 5 bearish.
  • PLX’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, PLX is a better buy in the short-term than NTLA.

Price Growth

NTLA (@Biotechnology) experienced а -20.95% price change this week, while PLX (@Biotechnology) price change was +6.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

NTLA is expected to report earnings on Feb 20, 2025.

PLX is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($2.13B) has a higher market cap than PLX($75M). PLX YTD gains are higher at: -36.517 vs. NTLA (-46.409). PLX has higher annual earnings (EBITDA): -12.12M vs. NTLA (-514.18M). NTLA has more cash in the bank: 691M vs. PLX (45M). PLX has less debt than NTLA: PLX (26.2M) vs NTLA (106M). NTLA has higher revenues than PLX: NTLA (46M) vs PLX (38.1M).
NTLAPLXNTLA / PLX
Capitalization2.13B75M2,844%
EBITDA-514.18M-12.12M4,241%
Gain YTD-46.409-36.517127%
P/E RatioN/A13.00-
Revenue46M38.1M121%
Total Cash691M45M1,536%
Total Debt106M26.2M405%
FUNDAMENTALS RATINGS
NTLA vs PLX: Fundamental Ratings
NTLA
PLX
OUTLOOK RATING
1..100
612
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
56
Fair valued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
9696
PRICE GROWTH RATING
1..100
9175
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTLA's Valuation (41) in the Biotechnology industry is in the same range as PLX (56) in the Servicestothe Health Industry industry. This means that NTLA’s stock grew similarly to PLX’s over the last 12 months.

NTLA's Profit vs Risk Rating (95) in the Biotechnology industry is in the same range as PLX (100) in the Servicestothe Health Industry industry. This means that NTLA’s stock grew similarly to PLX’s over the last 12 months.

NTLA's SMR Rating (96) in the Biotechnology industry is in the same range as PLX (96) in the Servicestothe Health Industry industry. This means that NTLA’s stock grew similarly to PLX’s over the last 12 months.

PLX's Price Growth Rating (75) in the Servicestothe Health Industry industry is in the same range as NTLA (91) in the Biotechnology industry. This means that PLX’s stock grew similarly to NTLA’s over the last 12 months.

PLX's P/E Growth Rating (99) in the Servicestothe Health Industry industry is in the same range as NTLA (100) in the Biotechnology industry. This means that PLX’s stock grew similarly to NTLA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NTLAPLX
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 20 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with BEAM. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+2.45%
BEAM - NTLA
69%
Closely correlated
+3.71%
VCYT - NTLA
69%
Closely correlated
+3.30%
EDIT - NTLA
67%
Closely correlated
+2.52%
CRSP - NTLA
64%
Loosely correlated
+4.96%
PRME - NTLA
61%
Loosely correlated
+4.47%
More

PLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLX has been loosely correlated with PCVX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PLX jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLX
1D Price
Change %
PLX100%
+4.63%
PCVX - PLX
43%
Loosely correlated
-0.12%
RCKT - PLX
40%
Loosely correlated
+2.64%
BEAM - PLX
39%
Loosely correlated
+3.71%
NTLA - PLX
39%
Loosely correlated
+2.45%
PRME - PLX
38%
Loosely correlated
+4.47%
More